Newsroom

VALENCIA, España--(BUSINESS WIRE)--Filippo Fagnani, director de marketing y del área científica de la división quirúrgica de Quanta System, ha recibido el premio de la Asociación Europea de Urología (EAU) por su destacada contribución a la endourología durante ICE 2026, la Conferencia Internacional de Endourología organizada por la sección de endourología de dicha asociación. El galardón reconoce más de dos décadas de dedicación a la tecnología láser y una trayectoria guiada por un objetivo cla...

VALENCIA, Spanje--(BUSINESS WIRE)--Filippo Fagnani, marketing- en wetenschappelijk directeur van de chirurgische divisie van Quanta System, is bekroond met een prijs voor zijn belangrijke bijdrage aan de endourologie tijdens ICE16, de internationale conferentie over endourologie die wordt georganiseerd door de sectie Endourologie van de EAU. Deze onderscheiding is een erkenning voor meer dan twee decennia van professionele toewijding aan lasertechnologie en een carrière die is opgebouwd rond ee...

VALENCIA, Spagna--(BUSINESS WIRE)--Filippo Fagnani, Direttore scientifico e del marketing della Divisione chirurgica dii Quanta System, è stato insignito del Significant Contribution to Endourology Award (Premio per il significativo contributo all'endourologia) nel corso di ICE26, la Conferenza internazionale sull'endourologia organizzata dalla Sezione endourologia dell'EAU (European Association of Urology, Associazione Europea di Urologia). Il riconoscimento celebra oltre vent'anni di impegno...

VALENCIA, Spanien--(BUSINESS WIRE)--Filippo Fagnani, Filippo Fagnani, Marketing- und Wissenschaftsdirektor der Surgical Division von Quanta System, wurde auf der ICE26 mit dem Preis für herausragende Beiträge zur Endourologie ausgezeichnet. Die ICE26 ist die von der EAU-Sektion für Endourologie organisierte Internationale Konferenz für Endourologie. Die Auszeichnung würdigt mehr als zwei Jahrzehnte beruflichen Engagements für die Lasertechnologie und eine Karriere, die von einem klaren Ziel gep...

VALENCE, Espagne--(BUSINESS WIRE)--Filippo Fagnani, directeur du marketing et directeur scientifique de la division chirurgicale de Quanta System, a reçu le Prix de la contribution significative au domaine de l’endourologie lors de l’ICE26, la conférence internationale sur l’endourologie organisée par la section d’endourologie de l’EAU (European Association of Urology). Cette distinction vient saluer plus de deux décennies d’engagement professionnel dans le domaine de la technologie des lasers...

LONDON--(BUSINESS WIRE)--  12-October-2026 Issue: Newday Funding Master Issuer Plc Series 2026-1 Class C RegS XS3375174045 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-September-2026 Date To: 15-October-2026 Record Date: 14-October-2026 Value Date: 15-October-2026 Benchmark Rate: 3.73629% Margin: 1.3% Total Rate: 5.03629% Number of Days: 30 Day Count: Actual / 365 (Fixed) Interest Frequency: Monthl...

BEVERLY, Mass.--(BUSINESS WIRE)--Medicinal Genomics launches next-day qPCR pathogen testing for dietary supplements, independently validated as equivalent to USP <2022> plating....

WILBRAHAM, Mass.--(BUSINESS WIRE)--Aceso Interactive and Alvee partner to bring AI-powered, whole-person care and personalized patient experiences directly to the bedside....

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 12 October 2026 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Com...

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 12 October 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, an...